Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 4, 2020
Net Sales Increased 13.4%Updates Guidance for the Fourth Quarter and Fiscal 2019Announces 180 Planned New Stores or 20% Unit Growth […]
Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C Inhibitor
REDWOOD CITY, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), announces a strategic collaboration to develop […]
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update
Xenon’s Proprietary Programs Continue to Advance with Multiple Mid to Late Stage Clinical Trials Anticipated to be Underway in 2020Xenon Eligible […]
Texas Roadhouse, Inc. to Announce Fourth Quarter Earnings on February 20, 2020
LOUISVILLE, Ky., Jan. 13, 2020 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH) announced today that it will release fourth […]
NXP Semiconductors Announces Conference Call to Review Fourth Quarter and Full-year 2019 Financial Results
EINDHOVEN, The Netherlands, Jan. 13, 2020 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it will release financial […]
Dave & Buster’s Reaffirms Fiscal 2019 Financial Outlook; Scheduled to Present at 2020 ICR Conference on Tuesday, January 14
DALLAS, Jan. 13, 2020 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an […]
MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — MOgene, a leading provider of genomic and bioinformatic services in […]
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
CAMBRIDGE, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare […]
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 13, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to […]
SELLAS Highlights Clinical Development Progress and Expected 2020 Milestones
– Phase 3 Galinpepimut-S (GPS) Acute Myeloid Leukemia (AML) Study Open for Enrollment and Patient Screening Underway – […]
